These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 18465126)
1. The power of synergy in the mediastinal staging of lung cancer. Lucignani G Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1388-91. PubMed ID: 18465126 [No Abstract] [Full Text] [Related]
2. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955 [TBL] [Abstract][Full Text] [Related]
3. Metabolic staging of lung cancer. Berlangieri SU; Scott AM N Engl J Med; 2000 Jul; 343(4):290-2. PubMed ID: 10911013 [No Abstract] [Full Text] [Related]
4. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Gould MK; Kuschner WG; Rydzak CE; Maclean CC; Demas AN; Shigemitsu H; Chan JK; Owens DK Ann Intern Med; 2003 Dec; 139(11):879-92. PubMed ID: 14644890 [TBL] [Abstract][Full Text] [Related]
6. Observer variation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in mediastinal staging of non-small cell lung cancer as a function of experience, and its potential clinical impact. Smulders SA; Gundy CM; van Lingen A; Comans EF; Smeenk FW; Hoekstra OS; Mol Imaging Biol; 2007; 9(5):318-22. PubMed ID: 17610119 [TBL] [Abstract][Full Text] [Related]
7. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer. Giaccone G J Natl Cancer Inst; 2007 Dec; 99(23):1741-3. PubMed ID: 18042929 [No Abstract] [Full Text] [Related]
8. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer. Weng E; Tran L; Rege S; Safa A; Sadeghi A; Juillard G; Mark R; Santiago S; Brown C; Mandelkern M Am J Clin Oncol; 2000 Feb; 23(1):47-52. PubMed ID: 10683077 [TBL] [Abstract][Full Text] [Related]
9. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer. Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911 [TBL] [Abstract][Full Text] [Related]
10. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. Pieterman RM; van Putten JW; Meuzelaar JJ; Mooyaart EL; Vaalburg W; Koëter GH; Fidler V; Pruim J; Groen HJ N Engl J Med; 2000 Jul; 343(4):254-61. PubMed ID: 10911007 [TBL] [Abstract][Full Text] [Related]
11. Multiple distant muscular metastases from non-small cell lung carcinoma evidenced by 18F-FDG PET/CT. Caobelli F; Pizzocaro C; Guerra UP Rev Esp Med Nucl Imagen Mol; 2013; 32(5):338-9. PubMed ID: 23809515 [No Abstract] [Full Text] [Related]
12. CT evaluation of mediastinal lymph nodes in lung cancer: influence of the lobar site of the primary neoplasm. Platt JF; Glazer GM; Gross BH; Quint LE; Francis IR; Orringer MB AJR Am J Roentgenol; 1987 Oct; 149(4):683-6. PubMed ID: 3498314 [TBL] [Abstract][Full Text] [Related]
13. Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer. Kunst PW; Lee P; Paul MA; Senan S; Smit EF J Thorac Oncol; 2007 Oct; 2(10):912-5. PubMed ID: 17909353 [TBL] [Abstract][Full Text] [Related]
14. Staging of non-small-cell lung cancer with positron-emission tomography. Rosell R N Engl J Med; 2000 Nov; 343(21):1572; author reply 1572-3. PubMed ID: 11184750 [No Abstract] [Full Text] [Related]
15. [Radiotherapy of lung cancer: Any room left for elective mediastinal irradiation in 2011?]. Van Houtte P; Roelandts M; Mornex F Cancer Radiother; 2011 Oct; 15(6-7):509-13. PubMed ID: 21873096 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer. Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164 [TBL] [Abstract][Full Text] [Related]
17. Staging of non-small-cell lung cancer with positron-emission tomography. Donckier JE; Roelants V; Pochet JM N Engl J Med; 2000 Nov; 343(21):1572; author reply 1572-3. PubMed ID: 11184751 [No Abstract] [Full Text] [Related]
18. How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer? Liewald F; Grosse S; Storck M; Guhlmann A; Halter G; Reske S; Sunder-Plassmann L Thorac Cardiovasc Surg; 2000 Apr; 48(2):93-6. PubMed ID: 11028710 [TBL] [Abstract][Full Text] [Related]
19. EBUS-TBNA for the mediastinal staging of non-small cell lung cancer. Navani N; Spiro SG; Janes SM J Thorac Oncol; 2009 Jun; 4(6):776; author reply 776-7. PubMed ID: 19461407 [No Abstract] [Full Text] [Related]
20. The diagnostic ability of Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]